Sentiment Trading

Cytophage Technologies Ltd. has received regulatory approval to begin studies on phage therapy, a potential game-changer for treating bacterial infections, marking a significant milestone for the biotech company.

Cytophage Technologies Ltd. is a Canadian biotech company focused on developing innovative cellular processing solutions, particularly for blood cell counting and sorting, despite its current financial challenges.